Spero Therapeutics, Inc. (29) | Intellectual Property (3)

Browse by Subcategory

License Agreements (3)

Recent Contracts

License Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc (Filed With SEC on August 5, 2021)
Amended and Restated License Agreement, dated January 15, 2021, by and between the Registrant and Everest Medicines II Limited (Filed With SEC on March 11, 2021)
License Agreement, dated January 4, 2019, by and between New Pharma License Holdings Limited and Everest Medicines II Limited (Filed With SEC on March 14, 2019)